Navigation Links
Obesity drug failing patients due to lack of education about side-effects
Date:5/8/2014

A new study, published today in the Journal of Health Psychology, found that patients who gained weight 18 months after taking Orlistat attributed their weight-loss failure either to the side effects which have prevented them from sticking to the medication or felt that the medication simply had not worked.

The team from the University of Surrey also found that participants described a series of barriers to weight loss including psychological and physical health issues, relationships and the make-up of their bodies. They also described a number of alternative methods of weight loss that had also failed, and the failure of Orlistat was included within this idea of permanent and ongoing failure.

Orlistat is currently the only prescribed drug for obesity and functions by reducing the amount of fat absorbed from food eaten.

"Our results have significant implications for GPs and how they should communicate with the patients about this drug," said lead author Dr Amelia Hollywood from the University of Surrey.

"GPs can improve patient support while taking Orlistat. At present, the so called "side effects" of Orlistat are seen as unpleasant and intrusive. If health professionals can highlight that such "side effects" are actually the consequences of eating high-fat foods while taking the drug, it could help ensure a change in diets.

"In addition, by alerting patients to these consequences and emphasising the need for dietary change, patients may be in a better position to make an informed judgement as to whether they wish to be prescribed this medication. GPs may likewise be able to make a more informed decision as to whether the medication should be prescribed, which could have cost implications for the NHS by reducing the waste of medications."


'/>"/>

Contact: Tanya Gubbay
t.gubbay@surrey.ac.uk
University of Surrey
Source:Eurekalert

Page: 1

Related medicine news :

1. Childhood obesity trends -- not time to celebrate, yet
2. Linking vascular inflammation to obesity and atherosclerosis
3. Snacking contributes to fatty liver and abdominal obesity
4. Early obesity linked to increased probability of severe obesity later in life
5. Motivational interviewing can positively impact childhood obesity
6. New myeloma-obesity research shows drugs can team with bodys defenses
7. Event to focus on obesity, diabetes and metabolic syndrome
8. Rules of thumb: 3 simple ideas for overcoming childhood obesity
9. Early-Life Influences on Obesity: From Pre-Conception to Adolescence
10. Discovery of anti-appetite molecule released by fiber could help tackle obesity
11. Study finds link between childs obesity and cognitive function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory Consortium ... . The site houses a wealth of federal resources that businesses can leverage ... called technology transfer (T2). As a network of over 300 federal laboratories, the ...
(Date:2/8/2016)... ... February 08, 2016 , ... A man who has struggled to quit smoking, a man ... , was determined to find solutions to his problems – and he did. Now Nabat, ... is ready to introduce his breakthrough inventions to the world and better people's lives. His ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Bell Agency, a full ... beneficiary of their ongoing community enrichment program. The current campaign fundraises for Angels ... are now being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & Doves was ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... frequently. While a significant number of women and men with eating disorders report ... itself, that best predicts the development of an eating disorder. , At ...
(Date:2/8/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to a product from ... a cluster of melanin when exposed to sunlight. Although most moles are benign and ... embarrassment. Historically, mole removal has involved a painful, often expensive visit to ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
(Date:2/8/2016)... February 8, 2016 ... published by Allied Market Research titled, "World ... Forecasts, 2014-2020", estimates the world synthetic biology market ... and sequencing technology segment would continue to lead ... tools segment, collectively, held around half of the ...
(Date:2/8/2016)... , 8. Februar 2016  LivaNova, ... heute eine Infografik mit dem Titel „Epilepsy ... Welt), mit der der Krankheit gegenüber ein ... dazu ermutigen soll, Medikamentenresistenz bei Epilepsie auf ... allgemeinen Diskussion zu machen. Mithilfe der neuen ...
Breaking Medicine Technology: